Status:
COMPLETED
Réa-MiniMax: Severe Acute Respiratory Failure in Hematology and Cancer Patients Without Bronchoalveolar Lavage
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Lymphoma
Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The MiniMax® study is a multicenter randomized controlled study aimed at demonstrating that a combination of non-invasive diagnostic tools are as effective as fiberoptic bronchoscopy and bronchoalveol...
Detailed Description
Acute respiratory failure is a dreadful complication in cancer patients. Indeed, about 20% of the patients will present with pulmonary infiltrates, but Intensive Care Unit (ICU) admission and mechanic...
Eligibility Criteria
Inclusion
- Patients with a malignant haemopathy or a cancer
- Patients with severe acute respiratory failure requiring admission to an ICU
- No argument for a congestive cardiac insufficiency (heart failure)
- Patients who provided their informed consent
Exclusion
- Age less than 18
- Patient who refuses to undergo fiberoptic bronchoscopy
- Therapeutic limitation
- Patients intubated at ICU admission
- Etiological diagnosis of the acute respiratory failure known
- Lack of available bronchoscopy
- AIDS
- Post-operative direct admission
- Inclusion in another research protocol in the ICU (HURRIET law)
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
206 Patients enrolled
Trial Details
Trial ID
NCT00248443
Start Date
August 1 2005
End Date
August 1 2008
Last Update
February 18 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Réanimation Médicale de l'Hôpital Saint-Louis
Paris, France, 75010